This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

A Roadmap to Key Pharmacologic Principles in Using Antipsychotics in the Treatment of Older Patients

George S. Alexopoulos, M.D.

Published: January 15, 2009

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Abstract

Antipsychotics are widely used to treat psychiatric disorders in older patients. While the growing number of second-generation antipsychotics (SGAs) has increased options for patients, it has also complicated clinical decision-making. Data from the American Psychiatric Association’s (APA’s ) Practice Research Network indicated disproportionately high use of antipsychotics and benzodiazepine medications among older patients compared with those under age 65.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: Populations

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Insights

LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Using data from the...

Read More...